Current Atherosclerosis Reports

, Volume 8, Issue 4, pp 304–309 | Cite as

Hemostatic therapy for intracerebral hemorrhage

  • Fred Rincon
  • Manuel M. Buitrago
  • Stephan A. Mayer


Despite the highest mortality and morbidity of all forms of stroke, few advances have been made in the management of intracerebral hemorrhage (ICH). Besides specialized care in the stroke or neurologic intensive care unit, until very recently no specific therapies have been shown to improve outcome after ICH. Ventilatory support, blood pressure reduction, intracranial pressure monitoring, osmotherapy, fever control, seizure prophylaxis, and nutritional supplementation are the cornerstones of supportive care in the intensive care unit. Recently, a phase II trial of recombinant activated factor VII (NovoSeven; Novo Nordisk, Bagsvaerd, Denmark) reduced hematoma expansion, mortality, and disability when given within 3 hours of ICH onset. A phase III trial to confirm these results is now in progress.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Sacco RL, Mayer SA: Epidemiology of intracerebral hemorrhage. In Intracerebral Hemorrhage. Edited by Feldmann E. Armonk, NY: Futura Publishing Co; 1994:3–23.Google Scholar
  2. 2.
    Broderick JP, Adams HP Jr, Barsan W, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999, 30:905–915.PubMedGoogle Scholar
  3. 3.
    Broderick JP, Brott TG, Duldner JE, et al.: Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993, 24:987–993.PubMedGoogle Scholar
  4. 4.
    Foulkes MA, Wolf PA, Price TR, et al.: The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 1988, 19:547–554.PubMedGoogle Scholar
  5. 5.
    Broderick JP, Brott T, Tomsick T: Importance of hypertension in lobar hemorrhages [abstract]. Neurology 1992, 42:181.Google Scholar
  6. 6.
    Weisberg LA, Stazio A, Shamsnia M, Elliot D: Nontraumatic parenchymal brain hemorrhages. Medicine (Baltimore) 1990, 69:277–295.Google Scholar
  7. 7.
    Wityk RJ, Caplan LR: Hypertensive intracerebral hemorrhage. Epidemiology and clinical pathology. Neurosurg Clin North Am 1992, 3:521–532.Google Scholar
  8. 8.
    Bonita R: Epidemiology of stroke. Lancet 1992, 339:342–344.PubMedCrossRefGoogle Scholar
  9. 9.
    Segal AZ, Chiu RI, Eggleston-Sexton PM, et al.: Low cholesterol as a risk factor for primary intracerebral hemorrhage: a case-control study. Neuroepidemiology. 1999, 18:185–193.PubMedCrossRefGoogle Scholar
  10. 10.
    Qureshi AI, Tuhrim S, Broderick JP, et al.: Spontaneous intracerebral hemorrhage. N Engl J Med 2001, 344:1450–1460.PubMedCrossRefGoogle Scholar
  11. 11.
    Kase C, Mohr JP: General Features of Intracranial Hemorrhage. New York: Churchill Livingstone; 1986.Google Scholar
  12. 12.
    Fisher C: Pathological observations in hypertensive intracerebral hemorrhage. J Neuropathol Exp Neurol 1971, 30:536–550.PubMedCrossRefGoogle Scholar
  13. 13.
    Mayer SA, Lignelli A, Fink ME, et al.: Perilesional blood flow and edema formation in acute intracerebral hemorrhage: a SPECT study. Stroke 1998, 29:1791–1798.PubMedGoogle Scholar
  14. 14.
    Fujii Y, Tanaka R, Takeuchi S, et al.: Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg 1994, 80:51–57.PubMedGoogle Scholar
  15. 15.
    Murai Y, Takagi R, Ikeda Y, et al.: Three-dimensional computerized tomography angiography in patients with hyperacute intracerebral hemorrhage. J Neurosurg 1999, 91:424–431.PubMedGoogle Scholar
  16. 16.
    Becker KJ, Baxter AB, Bybee HM, et al.: Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke 1999, 30:2025–2032.PubMedGoogle Scholar
  17. 17.
    Komiyama M, Yasui T, Tamura K, et al.: Simultaneous bleeding from multiple lenticulostriate arteries in hypertensive intracerebral haemorrhage. Neuroradiology 1995, 37:129–130.PubMedGoogle Scholar
  18. 18.
    Mizukami M, Araki G, Mihara H, et al.: Arteriographically visualized extravasation in hypertensive intracerebral hemorrhage. Report of seven cases. Stroke 1972, 3:527–537.PubMedGoogle Scholar
  19. 19.
    Takasugi S, Ueda S, Matsumoto K: Chronological changes in spontaneous intracerebral hematoma—an experimental and clinical study. Stroke 1985, 16:651–658.PubMedGoogle Scholar
  20. 20.
    Rosenberg GA, Navratil M: Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 1997, 48:921–926.PubMedGoogle Scholar
  21. 21.
    Lee KR, Colon GP, Betz AL, et al.: Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg 1996, 84:91–96.PubMedGoogle Scholar
  22. 22.
    Wagner KR, Xi G, Hua Y, et al.: Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke 1996, 27:490–497.PubMedGoogle Scholar
  23. 23.
    Yang GY, Betz AL, Hoff JT: The effects of blood or plasma clot on brain edema in the rat with intracerebral hemorrhage. Acta Neurochir Suppl (Wien) 1994, 60:555–557.Google Scholar
  24. 24.
    Broderick JP, Brott TG, Tomsick T, et al.: Ultra-early evaluation of intracerebral hemorrhage. J Neurosurg 1990, 72:195–199.PubMedGoogle Scholar
  25. 25.
    Chen ST, Chen SD, Hsu CY, Hogan EL: Progression of hypertensive intracerebral hemorrhage. Neurology 1989, 39:1509–1514.PubMedGoogle Scholar
  26. 26.
    Brott T, Broderick J, Kothari R, et al.: Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997, 28:1–5.PubMedGoogle Scholar
  27. 27.
    Fujitsu K, Muramoto M, Ikeda Y, et al.: Indications for surgical treatment of putaminal hemorrhage. Comparative study based on serial CT and time-course analysis. J Neurosurg 1990, 73:518–525.PubMedCrossRefGoogle Scholar
  28. 28.
    Kazui S, Naritomi H, Yamamoto H, et al.: Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 1996, 27:1783–1787.PubMedGoogle Scholar
  29. 29.
    Fujii Y, Takeuchi S, Sasaki O, et al.: Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998, 29:1160–1166.PubMedGoogle Scholar
  30. 30.
    Vermeer SE, Algra A, Franke CL, et al.: Long-term prognosis after recovery from primary intracerebral hemorrhage. Neurology 2002, 59:205–209.PubMedCrossRefGoogle Scholar
  31. 31.
    Nilsson OG, Lindgren A, Brandt L, Saveland H: Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg 2002, 97:531–536.PubMedGoogle Scholar
  32. 32.
    Daverat P, Castel JP, Dartigues JF, Orgogozo JM: Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke 1991, 22:1–6.PubMedGoogle Scholar
  33. 33.
    Hemphill JC 3rd, Bonovich DC, Besmertis L, et al.: The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001, 32:891–897.PubMedGoogle Scholar
  34. 34.
    Cheung RT, Zou LY: Use of the original, modified, or new intracerebral hemorrhage score to predict mortality and morbidity after intracerebral hemorrhage. Stroke 2003, 34:1717–1722.PubMedCrossRefGoogle Scholar
  35. 35.
    Mohr JP, Caplan LR, Melski JW, et al.: The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978, 28:754–762.PubMedGoogle Scholar
  36. 36.
    Wintzen AR, de Jonge H, Loeliger EA, Bots GT: The risk of intracerebral hemorrhage during oral anticoagulant therapy: a population study. Ann Neurol 1984, 16:553–558.PubMedCrossRefGoogle Scholar
  37. 37.
    Hart RG, Boop BS, Anderson DC: Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 1995, 26:1471–1477.PubMedGoogle Scholar
  38. 38.
    Fredriksson K, Norrving B, Stromblad LG: Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 1992, 23:972–977.PubMedGoogle Scholar
  39. 39.
    Heit JA: Perioperative management of the chronically anticoagulated patient. J Thromb Thrombolysis 2001, 12:81–87.PubMedCrossRefGoogle Scholar
  40. 40.
    Hart RG: Management of warfarin associated intracerebral hemorrhage. In UpToDate. Edited by Rose BD. Wellesley, MA: UpToDate; 2005.Google Scholar
  41. 41.
    Sorensen B, Johansen P, Nielsen GL, et al.: Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis 2003, 14:469–477.PubMedCrossRefGoogle Scholar
  42. 42.
    Erhardtsen E, Nony P, Dechavanne M, et al.: The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0. Blood Coagual Fibrinolysis. 1998, 9:741–748.CrossRefGoogle Scholar
  43. 43.
    Freeman WD, Brott TG, Barrett KM, et al.: Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 2004, 79:1495–1500.PubMedGoogle Scholar
  44. 44.
    Wakefield TW, Stanley JC: Intraoperative heparin anticoagulation and its reversal. Semin Vasc Surg 1996, 9:296–302.PubMedGoogle Scholar
  45. 45.
    Mannucci PM, Remuzzi G, Pusineri F, et al.: Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983, 308:8–12.PubMedCrossRefGoogle Scholar
  46. 46.
    Hedner U: Recombinant FVIIa. Vox Sang 2004, 87(Suppl 2):25–28.PubMedCrossRefGoogle Scholar
  47. 47.
    Monroe DM, Hoffman M, Oliver JA, Roberts HR: Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997, 99:542–547.PubMedCrossRefGoogle Scholar
  48. 48.
    Key NS, Aledort LM, Beardsley D, et al.: Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost 1998, 80:912–918.PubMedGoogle Scholar
  49. 49.
    Kenet G, Walden R, Eldad A, Martinowitz U: Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999, 354:1879.PubMedCrossRefGoogle Scholar
  50. 50.
    Hedner U: Recombinant activated factor VII as a universal haemostatic agent. Blood Coagul Fibrinolysis 1998, 9(Suppl 1):S147-S152.PubMedGoogle Scholar
  51. 51.
    Hedner U, Ingerslev J: Clinical use of recombinant FVIIa (rFVIIa). Transfus Sci 1998, 19:163–176.PubMedCrossRefGoogle Scholar
  52. 52.
    Rice KM, Savidge GF: NovoSeven (recombinant factor VIIa) in centeral nervous systems bleeds. Haemostasis 1996, 26(Suppl 1):131–134.PubMedGoogle Scholar
  53. 53.
    Mayer SA, Brun NC, Begtrup K, et al.: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005, 352:777–785.PubMedCrossRefGoogle Scholar
  54. 54.
    Boeer A, Voth E, Henze T, Prange HW: Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 1991, 54:466–467.PubMedGoogle Scholar
  55. 55.
    Mayer SA, Rincon F: Management of intracerebral hemorrhage. Lancet Neurol 2005, 4:662–672.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  • Fred Rincon
  • Manuel M. Buitrago
  • Stephan A. Mayer
    • 1
  1. 1.Division of Critical Care NeurologyNeurological InstituteNew YorkUSA

Personalised recommendations